Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Davis, Kenneth L.
Hollister, Leo E.
and
Fritz, William C.
1978.
Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol.
Life Sciences,
Vol. 23,
Issue. 15,
p.
1543.
Gelder, Michael
and
Kolakowska, Tamara
1979.
Variability of response to neuroleptics in schizophrenia: Clinical, pharmacologic, and neuroendocrine correlates.
Comprehensive Psychiatry,
Vol. 20,
Issue. 5,
p.
397.
Hamilton, M.
Card, I. R.
Wallis, G. G.
and
Mahmoud, M. R.
1979.
A comparative trial of the decanoates of flupenthixol and fluphenazine.
Psychopharmacology,
Vol. 64,
Issue. 2,
p.
225.
Baldessarini, Ross J.
and
Davis, John M.
1980.
What is the best maintenance dose of neuroleptics in schizophrenia?.
Psychiatry Research,
Vol. 3,
Issue. 2,
p.
115.
hall, John N.
1980.
Ward rating scales for long-stay patients: a review.
Psychological Medicine,
Vol. 10,
Issue. 2,
p.
277.
Angst, J.
and
Woggon, B.
1980.
Grundlagen und Methoden der Psychiatrie.
Vol. 1 / 2,
Issue. ,
p.
243.
Newman, Paul B.
1981.
The separation of meat from bone—A review of the mechanics and the problems.
Meat Science,
Vol. 5,
Issue. 3,
p.
171.
Mathur, S.
and
Hall, J. N.
1981.
Phenothiazine Withdrawal in Schizophrenics in a Hostel.
British Journal of Psychiatry,
Vol. 138,
Issue. 3,
p.
271.
Wistedt, B.
J�rgensen, A.
and
Wiles, D.
1982.
A depot neuroleptic withdrawal study.
Psychopharmacology,
Vol. 78,
Issue. 4,
p.
301.
Naber, D.
Albus, M.
Müller, F.
Münch, U.
Bürke, H.
Welter, D.
and
Ackenheil, M.
1984.
Forschungen zur Biologischen Psychiatrie.
p.
237.
Linden, Robert
Davis, John M.
and
Rubinstein, Joan
1984.
Guidelines for the Use of Psychotropic Drugs.
p.
151.
Wistedt, Börje
1985.
Psychiatry the State of the Art.
p.
751.
Browne, F.W.A.
Cooper, S.J.
Wilson, R.
and
King, D.J.
1988.
Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patients.
Journal of Psychopharmacology,
Vol. 2,
Issue. 2,
p.
94.
Kitamura, Toshinori
McGovern, Dermot A.
Imlah, Norman W.
Wiles, David
and
Schiff, Anthony A.
1988.
Plasma levels of fluphenazine and prolactin in psychiatric patients.
European Archives of Psychiatry and Neurological Sciences,
Vol. 237,
Issue. 6,
p.
320.
Carpenter, William T.
Kirkpatrick, Brian
and
Buchanan, Robert W.
1990.
Recent Advances in Schizophrenia.
p.
95.
Sramek, John J.
Gaurano, Valerie
Herrera, John M.
and
Potkin, Steven G.
1990.
Patterns of Neuroleptic Usage in Continuously Hospitalized Chronic Schizophrenic Patients: Evidence for Development of Drug Tolerance.
DICP,
Vol. 24,
Issue. 1,
p.
7.
Barnes, T. R. E.
and
Hirsch, S. R.
1991.
Guidelines for Neuroleptic Relapse Prevention in Schizophrenia.
p.
16.
King, D. J.
Blomqvist, M.
Cooper, S. J.
Doherty, M. M.
Mitchell, M. J.
and
Montgomery, R. C.
1992.
A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.
Psychopharmacology,
Vol. 107,
Issue. 2-3,
p.
175.
Buchanan, Robert W.
Kirkpatrick, Brian
Summerfelt, Ann
Hanlon, Thomas E.
Levine, Jerome
and
Carpenter, William T.
1992.
Clinical predictors of relapse following neuroleptic withdrawal.
Biological Psychiatry,
Vol. 32,
Issue. 1,
p.
72.
Davis, John M.
Janicak, Philip G.
Singla, Abhin
and
Sharma, Rajiv P.
1993.
Antipsychotic Drugs and their Side-Effects.
p.
183.
eLetters
No eLetters have been published for this article.